ETENDERS

Contract notice

Information

Published

Date of dispatch of this notice: 04/06/2020

Expire date: 06/07/2020

External Reference: 2020-232039

TED Reference: 2020/S 109-264031

Contract notice

Contract notice

Directive 2014/24/EU

Section I: Contracting authority

I.1)

Name and addresses

St James's Hospital
N/A
James Street
Dublin
Dublin 8
IE
Contact person: Pat Sullivan
Telephone: +353 14162468
E-mail: pfsullivan@stjames.ie
Internet address(es):
Main address: http://www.stjames.ie
Address of the buyer profile: https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/395

I.3)

Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at:  
http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=168016&B=ETENDERS_SIMPLE
Additional information can be obtained from
the abovementioned address:  
Tenders or requests to participate must be submitted
electronically via:  http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=168016&B=ETENDERS_SIMPLE
Tenders or requests to participate must be submitted
to the abovementioned address
I.4)

Type of the contracting authority

Body governed by public law
I.5)

Main activity

Health

Section II: Object

II.1)

Scope of the procurement

II.1.1)

Title

Invitation to tender for the provision of a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
II.1.2)

Main CPV code

38000000  -  Laboratory, optical and precision equipments (excl. glasses)
II.1.3)

Type of contract

Supplies
II.1.4)

Short description

The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancies. Currently this testing is conducted using standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. The laboratory is seeking to increase the number and repertoire of tests available to our clinical service users and to meet this demand will be focusing on developing and expanding our NGS based diagnostic assays. To facilitate this growth, the laboratory is seeking an NGS instrument with the capacity to process both small targeted gene single molecule molecular inversion probe (smMIP) based panels and larger pan-cancer (>500-gene) panels which will be performed on both tumour and paired normal material
II.1.5)

Estimated total value

Value excluding VAT: 1000000.00  EUR
II.1.6)

Information about lots

This contract is divided into lots: no
II.2)

Description

II.2.2)

Additional CPV code(s)

33124100  -  Diagnostic devices
33124110  -  Diagnostic systems
33696500  -  Laboratory reagents
51430000  -  Installation services of laboratory equipment
II.2.3)

Place of performance

Main site or place of performance:  
James Street
II.2.4)

Description of the procurement

The Cancer Molecular Diagnostics laboratory provides a range of molecular diagnostic tests for the diagnosis and management of haematological and solid malignancies. Currently this testing is conducted using standard PCR, real-time PCR and Next Generation Sequencing (NGS) based diagnostics. The laboratory is seeking to increase the number and repertoire of tests available to our clinical service users and to meet this demand will be focusing on developing and expanding our NGS based diagnostic assays. To facilitate this growth, the laboratory is seeking an NGS instrument with the capacity to process both small targeted gene single molecule molecular inversion probe (smMIP) based panels and larger pan-cancer (>500-gene) panels which will be performed on both tumour and paired normal material The proposed sequencer will be used by the laboratory in conjunction with our current diagnostic NGS set-up (Ion Chef and Ion Torrent S5 sequencers with Oncomine/AmpliSeq/smMIP library prep) with migration of assays between platforms envisaged over time as the demand and range of tests increases. Bioinformatic and library preparation solutions are not included in this tender.
II.2.5)

Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.6)

Estimated value

Value excluding VAT: 1000000.00  EUR
II.2.7)

Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 60
This contract is subject to renewal: no
II.2.10)

Information about variants

Variants will be accepted: no
II.2.11)

Information about options

Options: no
II.2.13)

Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no

Section III: Legal, economic, financial and technical information

III.1)

Conditions for participation

III.1.2)

Economic and financial standing

Selection criteria as stated in the procurement documents
III.1.3)

Technical and professional ability

Selection criteria as stated in the procurement documents
III.2)

Conditions related to the contract

Section IV: Procedure

IV.1)

Description

IV.1.1)

Type of procedure

Open procedure
IV.1.8)

Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement : no
IV.2)

Administrative information

IV.2.2)

Time limit for receipt of tenders or requests to participate

Date:  06/07/2020
Local time:  12:00
IV.2.4)

Languages in which tenders or requests to participate may be submitted

English
IV.2.7)

Conditions for opening of tenders

Date:  06/07/2020
Local time:  12:00

Section VI: Complementary information

VI.1)

Information about recurrence

This is a recurrent procurement:  no
VI.2)

Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used
VI.4)

Procedures for review

VI.4.1)

Review body

The High Court
Dublin City
Dublin
D1
IE